CAS: 1370556-82-3

Walsuralactam A in the formula I, which is used as an active ingredient, and is used for treating and preventing the tumour.

Walsuralactam A is a naturally occurring secondary metabolite, specifically a polyketide, which is derived from marine actinomycetes. The compound exhibits a unique bicyclo[3.2.1]octene core structure, making it structurally distinct among marine natural products. Its mode of action involves interference with bacterial biosynthesis pathways, particularly targeting and inhibiting the synthesis of vital cellular components necessary for bacterial growth and survival. The potential applications of Walsuralactam A are primarily in the realm of antimicrobial research. Current studies are focused on its efficacy against antibiotic-resistant bacterial strains, highlighting its significance in addressing the growing global challenge of antibiotic resistance. Additionally, its unique structure serves as a framework for synthetic modifications, providing insights into the design of novel pharmacophores. Further research into its bioactivity and pharmacokinetics is essential to fully elucidate its therapeutic potential and widen its possible applications in pharmaceutical development.